195 related articles for article (PubMed ID: 30984099)
1. A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation.
Zhao YH; Wang ZF; Pan ZY; Péus D; Delgado-Fernandez J; Pallud J; Li ZQ
Front Neurol; 2019; 10():286. PubMed ID: 30984099
[No Abstract] [Full Text] [Related]
2. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
3. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
[TBL] [Abstract][Full Text] [Related]
4. Survival after reoperation for recurrent glioblastoma multiforme: A prospective study.
Furtak J; Kwiatkowski A; Śledzińska P; Bebyn M; Krajewski S; Szylberg T; Birski M; Druszcz A; Krystkiewicz K; Gasiński P; Harat M
Surg Oncol; 2022 Jun; 42():101771. PubMed ID: 35512545
[TBL] [Abstract][Full Text] [Related]
5. Effects of Reoperation Timing on Survival among Recurrent Glioblastoma Patients: A Retrospective Multicentric Descriptive Study.
Kalita O; Kazda T; Reguli S; Jancalek R; Fadrus P; Slachta M; Pospisil P; Krska L; Vrbkova J; Hrabalek L; Smrcka M; Lipina R
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173996
[TBL] [Abstract][Full Text] [Related]
6. Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.
Lu VM; Goyal A; Graffeo CS; Perry A; Burns TC; Parney IF; Quinones-Hinojosa A; Chaichana KL
World Neurosurg; 2019 Jul; 127():31-37. PubMed ID: 30947000
[TBL] [Abstract][Full Text] [Related]
7. The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review.
Wang Y; Xing D; Zhao M; Wang J; Yang Y
PLoS One; 2016; 11(3):e0152170. PubMed ID: 27007828
[TBL] [Abstract][Full Text] [Related]
8. Does reintervention improve survival in recurrent glioblastoma? Facing a temporal bias in the literature.
Delgado-Fernández J; Frade-Porto N; Blasco G; González-Tarno P; Gil-Simoes R; Li ZQ; Rivas PP; de Sola RG
Acta Neurochir (Wien); 2020 Aug; 162(8):1967-1975. PubMed ID: 32556522
[TBL] [Abstract][Full Text] [Related]
9. Analyzing the role of reoperation in recurrent glioblastoma: a 15-year retrospective study in a single institution.
González V; Brell M; Fuster J; Moratinos L; Alegre D; López S; Ibáñez J
World J Surg Oncol; 2022 Dec; 20(1):384. PubMed ID: 36464682
[TBL] [Abstract][Full Text] [Related]
10. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
11. Reoperation for Recurrent Glioblastoma Multiforme.
Robin AM; Lee I; Kalkanis SN
Neurosurg Clin N Am; 2017 Jul; 28(3):407-428. PubMed ID: 28600015
[TBL] [Abstract][Full Text] [Related]
12. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
[TBL] [Abstract][Full Text] [Related]
13. National Trends for Reoperation in Older Patients with Glioblastoma.
Chen YR; Sole J; Ugiliweneza B; Johnson E; Burton E; Woo SY; Koutourousiou M; Williams B; Boakye M; Skirboll S
World Neurosurg; 2018 May; 113():e179-e189. PubMed ID: 29427817
[TBL] [Abstract][Full Text] [Related]
14. γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
Skeie BS; Enger PØ; Brøgger J; Ganz JC; Thorsen F; Heggdal JI; Pedersen PH
World Neurosurg; 2012 Dec; 78(6):658-69. PubMed ID: 22484078
[TBL] [Abstract][Full Text] [Related]
15. Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.
Kaka N; Hafazalla K; Samawi H; Simpkin A; Perry J; Sahgal A; Das S
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689995
[TBL] [Abstract][Full Text] [Related]
16. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
17. Reoperation in adult patients with recurrent glioblastoma: A matched cohort analysis.
Yang K; Ellenbogen Y; Martyniuk A; Sourour M; Takroni R; Somji M; Gardiner E; Hui K; Odedra D; Larrazabal R; Algird A; Kachur E; Reddy K; Murty N; Farrokhyar F; Singh SK
Neurooncol Adv; 2022; 4(1):vdac115. PubMed ID: 35990706
[TBL] [Abstract][Full Text] [Related]
18. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis.
Kazmi F; Soon YY; Leong YH; Koh WY; Vellayappan B
J Neurooncol; 2019 Mar; 142(1):79-90. PubMed ID: 30523605
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
